Dermatofibroma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Dermatofibroma}} | {{Dermatofibroma}} | ||
{{CMG}} | {{CMG}}, {{AE}}{{Homa}} | ||
==Overview== | ==Overview== | ||
Revision as of 18:28, 5 June 2019
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma epidemiology and demographics |
|
Risk calculators and risk factors for Dermatofibroma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Dermatofibromas occur most often in women; the male to female ratio is about 1:4. The age group in which they most commonly occur is twenty to forty-five years.
Epidemiology and Demographics
Dermatofibromas occur most often in women; the male to female ratio is about 1:4. The age group in which they most commonly occur is twenty to forty-five years.